Optimizing Phase III Trials in Pancreatic Cancer - ESMO Poster 2024

Using the Aurora Suite we compared the phase III trial 'POLO' with our results. The Aurora Suite could have enabled POLO to enroll more than 200% higher, whilst reducing sites required and enrollment time by ~30%.